메뉴 건너뛰기




Volumn 12, Issue 10, 2014, Pages 1626-1635

Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: A cohort study

Author keywords

Arthroplasty; Low molecular weight heparin; Prophylaxis; Rivaroxaban; Venous thromboembolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; RIVAROXABAN; TINZAPARIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

EID: 84907865124     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12675     Document Type: Article
Times cited : (23)

References (37)
  • 1
    • 84896281400 scopus 로고    scopus 로고
    • Epidemiology and variability of orthopaedic procedures worldwide
    • Bentley G, ed edn. 12th EFORT Congress, Copenhagen, Denmark. Berlin, Germany: Springer
    • de Pina MDF, Ribeiro AI, Santos C. Epidemiology and variability of orthopaedic procedures worldwide. In: Bentley G, ed. European Instructional Lectures Vol. 11, 11 edn. 12th EFORT Congress, Copenhagen, Denmark. Berlin, Germany: Springer, 2011: 9-19.
    • (2011) European Instructional Lectures , vol.11 , pp. 9-19
    • de Pina, M.D.F.1    Ribeiro, A.I.2    Santos, C.3
  • 2
    • 34147150632 scopus 로고    scopus 로고
    • Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030
    • Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg 2007; 89: 780-5.
    • (2007) J Bone Joint Surg , vol.89 , pp. 780-785
    • Kurtz, S.1    Ong, K.2    Lau, E.3    Mowat, F.4    Halpern, M.5
  • 5
    • 46049090201 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    • Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S.
    • (2008) Chest , vol.133 , pp. 381S-453S
    • Geerts, W.H.1    Bergqvist, D.2    Pineo, G.F.3    Heit, J.A.4    Samama, C.M.5    Lassen, M.R.6    Colwell, C.W.7
  • 7
    • 0030603839 scopus 로고    scopus 로고
    • Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo
    • Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 48: 224-8.
    • (1996) Lancet , vol.48 , pp. 224-228
    • Planes, A.1    Vochelle, N.2    Darmon, J.Y.3    Fagola, M.4    Bellaud, M.5    Huet, Y.6
  • 9
    • 33745632369 scopus 로고    scopus 로고
    • Venous thromboembolism following major orthopedic surgery: what is the risk after discharge?
    • Arcelus JI, Kudrna JC, Caprini JA. Venous thromboembolism following major orthopedic surgery: what is the risk after discharge? Orthopedics 2006; 29: 506-16.
    • (2006) Orthopedics , vol.29 , pp. 506-516
    • Arcelus, J.I.1    Kudrna, J.C.2    Caprini, J.A.3
  • 10
    • 84879555624 scopus 로고    scopus 로고
    • Clinical review: clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications
    • Lazo-Langner A, Lang E, Douketis J. Clinical review: clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care 2013; 17: 230.
    • (2013) Crit Care , vol.17 , pp. 230
    • Lazo-Langner, A.1    Lang, E.2    Douketis, J.3
  • 11
    • 46049106502 scopus 로고    scopus 로고
    • Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
    • Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372: 31-9.
    • (2008) Lancet , vol.372 , pp. 31-39
    • Kakkar, A.K.1    Brenner, B.2    Dahl, O.E.3    Eriksson, B.I.4    Mouret, P.5    Muntz, J.6    Soglian, A.G.7    Pap, A.F.8    Misselwitz, F.9    Haas, S.10
  • 14
    • 34250651947 scopus 로고    scopus 로고
    • Dose-escalation study of rivaroxaban (BAY 59-7939)-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism in patients undergoing total hip replacement
    • Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, Muehlhofer E, Kalebo P. Dose-escalation study of rivaroxaban (BAY 59-7939)-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism in patients undergoing total hip replacement. Thromb Res 2007; 120: 685-93.
    • (2007) Thromb Res , vol.120 , pp. 685-693
    • Eriksson, B.I.1    Borris, L.C.2    Dahl, O.E.3    Haas, S.4    Huisman, M.V.5    Kakkar, A.K.6    Misselwitz, F.7    Muehlhofer, E.8    Kalebo, P.9
  • 15
    • 28444474155 scopus 로고    scopus 로고
    • BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study
    • Turpie AG, Fisher WD, Bauer KA, Kwong LM, Irwin MW, Kalebo P, Misselwitz F, Gent M. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost 2005; 3: 2479-86.
    • (2005) J Thromb Haemost , vol.3 , pp. 2479-2486
    • Turpie, A.G.1    Fisher, W.D.2    Bauer, K.A.3    Kwong, L.M.4    Irwin, M.W.5    Kalebo, P.6    Misselwitz, F.7    Gent, M.8
  • 19
    • 84863224773 scopus 로고    scopus 로고
    • Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
    • Gomez-Outes A, Terleira-Fernandez AI, Suarez-Gea ML, Vargas-Castrillon E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. Br Med J 2012; 344: e3675.
    • (2012) Br Med J , vol.344 , pp. e3675
    • Gomez-Outes, A.1    Terleira-Fernandez, A.I.2    Suarez-Gea, M.L.3    Vargas-Castrillon, E.4
  • 20
    • 53449094159 scopus 로고    scopus 로고
    • Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies
    • Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 2008; 118: 1294-303.
    • (2008) Circulation , vol.118 , pp. 1294-1303
    • Nallamothu, B.K.1    Hayward, R.A.2    Bates, E.R.3
  • 21
    • 0029912547 scopus 로고    scopus 로고
    • Why we need observational studies to evaluate the effectiveness of health care
    • Black N. Why we need observational studies to evaluate the effectiveness of health care. Br Med J 1996; 312: 1215-8.
    • (1996) Br Med J , vol.312 , pp. 1215-1218
    • Black, N.1
  • 22
    • 85028124448 scopus 로고    scopus 로고
    • Estimates of population, by age group and sex
    • Accessed 26 August 2013.
    • Statistics Canada. Estimates of population, by age group and sex. Canadian Socioeconomic Database. 2013. http://www5.statcan.gc.ca/cansim/home-accueil?lang=eng. Accessed 26 August 2013.
    • (2013) Canadian Socioeconomic Database
  • 24
    • 33744506249 scopus 로고    scopus 로고
    • Accuracy of coding for possible warfarin complications in hospital discharge abstracts
    • Arnason T, Wells PS, van Walraven C, Forster AJ. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res 2006; 118: 253-62.
    • (2006) Thromb Res , vol.118 , pp. 253-262
    • Arnason, T.1    Wells, P.S.2    van Walraven, C.3    Forster, A.J.4
  • 26
    • 0029878321 scopus 로고    scopus 로고
    • Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison
    • Jha P, Deboer D, Sykora K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol 1996; 27: 1335-42.
    • (1996) J Am Coll Cardiol , vol.27 , pp. 1335-1342
    • Jha, P.1    Deboer, D.2    Sykora, K.3    Naylor, C.D.4
  • 27
    • 70449641720 scopus 로고    scopus 로고
    • Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research
    • Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput 2009; 38: 1228-34.
    • (2009) Commun Stat Simul Comput , vol.38 , pp. 1228-1234
    • Austin, P.C.1
  • 28
    • 0032580320 scopus 로고    scopus 로고
    • Two-sided confidence intervals for the single proportion: comparison of seven methods
    • Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17: 857-72.
    • (1998) Stat Med , vol.17 , pp. 857-872
    • Newcombe, R.G.1
  • 29
    • 66149131082 scopus 로고    scopus 로고
    • The relative merits of risk ratios and odds ratios
    • Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med 2009; 163: 438-45.
    • (2009) Arch Pediatr Adolesc Med , vol.163 , pp. 438-445
    • Cummings, P.1
  • 30
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 31
    • 85028096516 scopus 로고    scopus 로고
    • OpenEpi: open source epidemiologic statistics for public health. Version 3.01. Accessed 4 June 2013.
    • Dean AG, Sullivan KM, Soe MM. OpenEpi: open source epidemiologic statistics for public health. Version 3.01. www.OpenEpi.com. Accessed 4 June 2013.
    • Dean, A.G.1    Sullivan, K.M.2    Soe, M.M.3
  • 32
    • 84891851890 scopus 로고    scopus 로고
    • A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment
    • Turpie AG, Haas S, Kreutz R, Mantovani LG, Pattanayak CW, Holberg G, Jamal W, Schmidt A, van Eickels M, Lassen MR. A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17, 701 patients with propensity score adjustment. Thromb Haemost 2014; 111: 94-102.
    • (2014) Thromb Haemost , vol.111 , pp. 94-102
    • Turpie, A.G.1    Haas, S.2    Kreutz, R.3    Mantovani, L.G.4    Pattanayak, C.W.5    Holberg, G.6    Jamal, W.7    Schmidt, A.8    van Eickels, M.9    Lassen, M.R.10
  • 33
    • 84904549901 scopus 로고    scopus 로고
    • Toronto, ON, Canada: Queen's Printer for Ontario
    • Ontario Ministry of Finance. Ontario Population Projections Update 2012-2036. Toronto, ON, Canada: Queen's Printer for Ontario, 2013.
    • (2013) Ontario Population Projections Update 2012-2036
  • 34
    • 79952001310 scopus 로고    scopus 로고
    • Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database
    • Tagalakis V, Kahn SR. Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database. Pharmacoepidemiol Drug Saf 2011; 20: 304-7.
    • (2011) Pharmacoepidemiol Drug Saf , vol.20 , pp. 304-307
    • Tagalakis, V.1    Kahn, S.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.